Jin Medical International (ZJYL) Receivables - Other (2022 - 2025)

Jin Medical International (ZJYL) has reported Receivables - Other for 4 consecutive years, with $152173.0 the latest figure, recorded in Q3 2025.

• Quarterly Receivables - Other fell 16.07% year-over-year to $152173.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $152173.0 (down 16.07% YoY) and the FY2025 annual result came in at $14.3 million, up 10.52% from the prior year.
• Receivables - Other slipped to $152173.0 in Q3 2025 per ZJYL's latest filing, from $12.6 million in the prior quarter.
• Over the last five years, Receivables - Other for ZJYL reached as high as $12.6 million in Q1 2025 and fell as low as -$569807.0 in Q1 2024.
• A 4-year average of $3.6 million and a median of $181309.0 in 2024 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2023 — Receivables - Other jumped 5768.14% — and 2024, when it plunged 111.69%.
• Year by year, Receivables - Other stood at $131449.0 in 2022, then soared by 5768.14% to $7.7 million in 2023, then slumped by 97.65% to $181309.0 in 2024, then fell by 16.07% to $152173.0 in 2025.
• According to Business Quant data, Receivables - Other over the past three periods registered $152173.0, $12.6 million, and $181309.0 for Q3 2025, Q1 2025, and Q3 2024 respectively.